These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 20362550)

  • 1. Maintained activity of glycogen synthase kinase-3beta despite of its phosphorylation at serine-9 in okadaic acid-induced neurodegenerative model.
    Lim YW; Yoon SY; Choi JE; Kim SM; Lee HS; Choe H; Lee SC; Kim DH
    Biochem Biophys Res Commun; 2010 Apr; 395(2):207-12. PubMed ID: 20362550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
    Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
    Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new indirubin derivative inhibitors of glycogen synthase kinase-3, 6-BIDECO and 6-BIMYEO, prevent tau phosphorylation and apoptosis induced by the inhibition of protein phosphatase-2A by okadaic acid in cultured neurons.
    Martin L; Magnaudeix A; Wilson CM; Yardin C; Terro F
    J Neurosci Res; 2011 Nov; 89(11):1802-11. PubMed ID: 21826701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau phosphorylation and neuronal apoptosis induced by the blockade of PP2A preferentially involve GSK3β.
    Martin L; Page G; Terro F
    Neurochem Int; 2011 Aug; 59(2):235-50. PubMed ID: 21672577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium chloride and staurosporine potentiate the accumulation of phosphorylated glycogen synthase kinase 3β/Tyr216, resulting in glycogen synthase kinase 3β activation in SH-SY5Y human neuroblastoma cell lines.
    Noël A; Barrier L; Rinaldi F; Hubert C; Fauconneau B; Ingrand S
    J Neurosci Res; 2011 May; 89(5):755-63. PubMed ID: 21360572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide induces tau hyperphosphorylation via glycogen synthase kinase-3beta activation.
    Zhang YJ; Xu YF; Liu YH; Yin J; Wang JZ
    FEBS Lett; 2005 Nov; 579(27):6230-6. PubMed ID: 16253246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A.
    Nicolia V; Fuso A; Cavallaro RA; Di Luzio A; Scarpa S
    J Alzheimers Dis; 2010; 19(3):895-907. PubMed ID: 20157245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer's disease models.
    Zhang H; Wang X; Xu P; Ji X; Chi T; Liu P; Zou L
    J Physiol Sci; 2020 Jun; 70(1):29. PubMed ID: 32517647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSK-3 mediates the okadaic acid-induced modification of collapsin response mediator protein-2 in human SK-N-SH neuroblastoma cells.
    Ni MH; Wu CC; Chan WH; Chien KY; Yu JS
    J Cell Biochem; 2008 Apr; 103(6):1833-48. PubMed ID: 17902168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src.
    Yao XQ; Zhang XX; Yin YY; Liu B; Luo DJ; Liu D; Chen NN; Ni ZF; Wang X; Wang Q; Wang JZ; Liu GP
    Biochem J; 2011 Jul; 437(2):335-44. PubMed ID: 21554241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidins220 accumulates with tau in human Alzheimer's disease and related models: modulation of its calpain-processing by GSK3β/PP1 imbalance.
    López-Menéndez C; Gamir-Morralla A; Jurado-Arjona J; Higuero AM; Campanero MR; Ferrer I; Hernández F; Ávila J; Díaz-Guerra M; Iglesias T
    Hum Mol Genet; 2013 Feb; 22(3):466-82. PubMed ID: 23118350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of GSK-3beta in okadaic acid-induced neurodegeneration: relevance to Alzheimer's disease.
    Yoon SY; Choi JE; Huh JW; Hwang O; Nam Hong H; Kim D
    Neuroreport; 2005 Feb; 16(3):223-7. PubMed ID: 15706224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism.
    Li T; Paudel HK
    Biochemistry; 2006 Mar; 45(10):3125-33. PubMed ID: 16519507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death.
    Chen G; Bower KA; Ma C; Fang S; Thiele CJ; Luo J
    FASEB J; 2004 Jul; 18(10):1162-4. PubMed ID: 15132987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GSK3β inhibitor, TDZD-8, rescues cognition in a zebrafish model of okadaic acid-induced Alzheimer's disease.
    Koehler D; Shah ZA; Williams FE
    Neurochem Int; 2019 Jan; 122():31-37. PubMed ID: 30392874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14-3-3zeta facilitates GSK3beta-catalyzed tau phosphorylation in HEK-293 cells by a mechanism that requires phosphorylation of GSK3beta on Ser9.
    Li T; Paudel HK
    Neurosci Lett; 2007 Mar; 414(3):203-8. PubMed ID: 17317006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease.
    Uchida Y; Ohshima T; Sasaki Y; Suzuki H; Yanai S; Yamashita N; Nakamura F; Takei K; Ihara Y; Mikoshiba K; Kolattukudy P; Honnorat J; Goshima Y
    Genes Cells; 2005 Feb; 10(2):165-79. PubMed ID: 15676027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin Protects against Okadaic Acid-Induced Injury via MAPK and PI3K/Akt/GSK3β Signaling Pathways in HT22 Hippocampal Neurons.
    Jiang W; Luo T; Li S; Zhou Y; Shen XY; He F; Xu J; Wang HQ
    PLoS One; 2016; 11(4):e0152371. PubMed ID: 27050422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse.
    Planel E; Yasutake K; Fujita SC; Ishiguro K
    J Biol Chem; 2001 Sep; 276(36):34298-306. PubMed ID: 11441005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
    Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
    Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.